Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for apathy, motor symptoms, and mood in Parkinson's disease
2012-002840-26Phase 4Completed
- Sponsor
- UCB
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rotigotine in Parkinson's disease (PD) (3 arms), sponsored by UCB. Primary endpoint: Change from baseline to end of maintenance period in Apathy Scale score rated by the subject. Started Nov 2012; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2012-002840-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002840-26.